Page last updated: 2024-12-06

nco 650

Description Research Excerpts Clinical Trials Roles Classes Pathways Study Profile Bioassays Related Drugs Related Conditions Protein Interactions Research Growth

Description

NCO 650: RN given refers to (trans)-isomer [Medical Subject Headings (MeSH), National Library of Medicine, extracted Dec-2023]

Cross-References

ID SourceID
PubMed CID3068364
SCHEMBL ID11079703
SCHEMBL ID8531534
MeSH IDM0115384

Synonyms (18)

Synonym
batebulast hydrochloride
nco-650
trans-4-guanidinomethylcyclohexanecarboxylic acid p-tert-butylphenyl ester hydrochloride
nco 650
cyclohexanecarboxylic acid, 4-(((aminoiminomethyl)amino)methyl)-, 4-(1,1-dimethylethyl)phenyl ester, monohydrochloride, trans-
9mah4pfe2a ,
83373-31-3
unii-9mah4pfe2a
SCHEMBL11079703
SCHEMBL8531534
trans-4-guanidinomethylcyclohexanecarboxylic acid p-t-butylphenyl ester hydrochloride
D11103
batebulast hydrochloride (jan)
4-tert-butylphenyl 4-(carbamimidamidomethyl)cyclohexane-1-carboxylate--hydrogen chloride (1/1)
DTXSID701003369
nco650
cyclohexanecarboxylic acid, 4-(((aminoiminomethyl)amino)methyl)-, 4-(1,1-dimethylethyl)phenyl ester, hydrochloride (1:1), trans-
batebulast hydrochloride [jan]
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Research

Studies (24)

TimeframeStudies, This Drug (%)All Drugs %
pre-199014 (58.33)18.7374
1990's9 (37.50)18.2507
2000's1 (4.17)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Study Types

Publication TypeThis drug (%)All Drugs (%)
Trials0 (0.00%)5.53%
Reviews0 (0.00%)6.00%
Case Studies0 (0.00%)4.05%
Observational0 (0.00%)0.25%
Other24 (100.00%)84.16%
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]